Subversive Acquisition LP Provides Update on Qualifying Transaction Apr 10, 2021 09:58PM

TORONTO, April 10, 2021 (GLOBE NEWSWIRE) -- SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that closing of its qualifying transaction to combine with InterCure Ltd. (dba Canndoc) (TASE: INCR), Israel’s leading cannabis company, is expected to occur as soon as practicable after the outstanding conditions to closing are met, which SVX expects to be on or before April 20, 2021.

About SVX

Subversive Acquisition LP is a... (continue reading...)


FSIS ISSUES PUBLIC HEALTH ALERT FOR RAW GROUND TURKEY PRODUCTS LINKED TO SALMONELLA HADAR ILLNESS Apr 10, 2021 07:56PM

Washington, D.C., April 10, 2021 (GLOBE NEWSWIRE) --

                                                                         Public Health Alert   Congressional and Public Affairs Veronica Pegram-Williams  (202) 720-9113 FSISpress@usda.gov   FSIS ISSUES PUBLIC HEALTH ALERT FOR RAW GROUND TURKEY PRODUCTS LINKED TO SALMONELLA HADAR ILLNESS     WASHINGTON, APRIL 10, 2021 – The U.S.... (continue reading...)
FSIS ISSUES PUBLIC HEALTH ALERT FOR RAW GROUND TURKEY PRODUCTS LINKED TO SALMONELLA HADAR ILLNESS Apr 10, 2021 07:56PM

Washington, D.C., April 10, 2021 (GLOBE NEWSWIRE) --

                                                                         Public Health Alert   Congressional and Public Affairs Veronica Pegram-Williams  (202) 720-9113 FSISpress@usda.gov   FSIS ISSUES PUBLIC HEALTH ALERT FOR RAW GROUND TURKEY PRODUCTS LINKED TO SALMONELLA HADAR ILLNESS     WASHINGTON, APRIL 10, 2021 – The U.S.... (continue reading...)
GLOBAL TECH INDUSTRIES GROUP, INC. SIGNS LETTER OF INTENT WITH ALT 5 SIGMA, INC. TO EXPLORE BUSINESS COMBINATION Apr 10, 2021 05:05PM

New York, NY, April 10, 2021 (GLOBE NEWSWIRE) -- (GTII:OTCQB) Global Tech Industries Group, Inc. (OTCQB: GTII) (“GTII” or the “Company”), www.gtii-us.com, a Nevada corporation announced on April 9, 2021, that the Company had engaged Alt5 Sigma, Inc. to provide the platform for creating NFTs for its upcoming art assets, as well as future assets requiring tokenization. During their discussions, both companies recognized that a unique synergy may exist between... (continue reading...)


GLOBAL TECH INDUSTRIES GROUP, INC. SIGNS LETTER OF INTENT WITH ALT 5 SIGMA, INC. TO EXPLORE BUSINESS COMBINATION Apr 10, 2021 05:05PM

New York, NY, April 10, 2021 (GLOBE NEWSWIRE) -- (GTII:OTCQB) Global Tech Industries Group, Inc. (OTCQB: GTII) (“GTII” or the “Company”), www.gtii-us.com, a Nevada corporation announced on April 9, 2021, that the Company had engaged Alt5 Sigma, Inc. to provide the platform for creating NFTs for its upcoming art assets, as well as future assets requiring tokenization. During their discussions, both companies recognized that a unique synergy may exist between... (continue reading...)


More Globe Newswire

View Older Stories

Apr 10, 2021 03:54PM Cameco remettra en service sa mine de Cigar Lake en avril
Apr 10, 2021 03:05PM C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
Apr 10, 2021 03:05PM C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
Apr 10, 2021 02:20PM iRhythm® Technologies Announces Conference Call to Discuss Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication
Apr 10, 2021 02:00PM Brisbane 8th Grader, Joshua Wood, Takes Home the Grand Prize in Lions Clubs International Peace Essay Contest
Apr 10, 2021 02:00PM Brisbane 8th Grader, Joshua Wood, Takes Home the Grand Prize in Lions Clubs International Peace Essay Contest
Apr 10, 2021 02:00PM 24 CHILDREN FROM AROUND THE WORLD NAMED AS FINALISTS IN LIONS CLUBS INTERNATIONAL’S PEACE POSTER CONTEST
Apr 10, 2021 02:00PM 24 CHILDREN FROM AROUND THE WORLD NAMED AS FINALISTS IN LIONS CLUBS INTERNATIONAL’S PEACE POSTER CONTEST
Apr 10, 2021 01:31PM PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021
Apr 10, 2021 01:31PM Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
Apr 10, 2021 01:30PM Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session at AACR on ZN-c3, its WEE1 Inhibitor, in Patients with Advanced Solid Tumors
Apr 10, 2021 01:30PM Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session at AACR on ZN-c3, its WEE1 Inhibitor, in Patients with Advanced Solid Tumors
Apr 10, 2021 01:20PM CORRECTION - With New SVP of Sales, Ushur Adds Sixth Senior Leader in Six Months
Apr 10, 2021 01:00PM BitMart Exchange Partners with MoonPay to Advance Fiat-to-Crypto Transaction
Apr 10, 2021 01:00PM BitMart Exchange Partners with MoonPay to Advance Fiat-to-Crypto Transaction
Apr 10, 2021 10:02AM Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer Types
Apr 10, 2021 10:02AM Theratechnologies présente de nouvelles données précliniques in vivo démontrant une importante activité antitumorale du TH1902 dans tous les types de cancers étudiés
Apr 10, 2021 09:22AM F-star Therapeutics Shows Differentiation of FS222 in 2021 AACR Poster
Apr 10, 2021 09:22AM F-star Therapeutics Shows Differentiation of FS222 in 2021 AACR Poster
Apr 10, 2021 09:00AM Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT-1660 in Three Posters at Virtual 2021 AACR Annual Meeting
Apr 10, 2021 08:35AM New Clinical Responses for AGEN1181 Presented at AACR
Apr 10, 2021 08:35AM New Clinical Responses for AGEN1181 Presented at AACR
Apr 10, 2021 08:31AM Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting
Apr 10, 2021 08:31AM TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting
Apr 10, 2021 08:31AM TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting
Apr 10, 2021 08:31AM HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers
Apr 10, 2021 08:31AM HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers
Apr 10, 2021 08:31AM Advaxis Presents Translational Biomarker Data from Ongoing ADXS-503 Phase 1/2 Lung Cancer Trial at the American Associated for Cancer Research (AACR) 2021 Annual Meeting
Apr 10, 2021 08:31AM Arch Oncology Presents New Preclinical T-ALL Data on Highly-differentiated Anti-CD47 Antibody AO-176 at AACR 2021
Apr 10, 2021 08:31AM Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021
Apr 10, 2021 08:31AM CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell Function
Apr 10, 2021 08:30AM Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021
Apr 10, 2021 08:30AM Inivata Presents New Data in Support of its Liquid Biopsy Technologies at AACR Virtual Annual Meeting 2021
Apr 10, 2021 08:30AM Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
Apr 10, 2021 08:30AM Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001
Apr 10, 2021 08:30AM Kymera Therapeutics Presents Late-Breaking Preclinical Data Highlighting Superiority of Dual-Targeting Activity of IRAKIMiD Degrader KT-413 at AACR Annual Meeting 2021
Apr 10, 2021 08:30AM Harpoon Therapeutics Announces Data from Poster Presentations at the AACR Annual Meeting 2021
Apr 10, 2021 08:30AM Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Re
Apr 10, 2021 08:30AM Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
Apr 10, 2021 08:30AM MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
Apr 10, 2021 08:30AM Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
Apr 10, 2021 08:30AM Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
Apr 10, 2021 08:30AM OncXerna Therapeutics Provides New Results from its Xerna™ RNA-based Biomarker Platform at the AACR Annual Meeting
Apr 10, 2021 08:30AM Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001
Apr 10, 2021 08:30AM Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Re
Apr 10, 2021 08:30AM iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021
Apr 10, 2021 08:30AM NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021
Apr 10, 2021 08:30AM Harpoon Therapeutics Announces Data from Poster Presentations at the AACR Annual Meeting 2021
Apr 10, 2021 08:30AM Gennao Bio Presents New Data on Novel Gene Monoclonal Antibody Platform Technology at the American Association for Cancer Research (AACR) 2021 Annual Meeting
Apr 10, 2021 08:30AM MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
View Older Stories